(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 2.9% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 5.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.87%.
Perrigo Co's revenue in 2024 is $4,392,000,000.On average, 4 Wall Street analysts forecast PRGO's revenue for 2024 to be $605,264,271,719, with the lowest PRGO revenue forecast at $602,129,297,211, and the highest PRGO revenue forecast at $607,431,154,530. On average, 4 Wall Street analysts forecast PRGO's revenue for 2025 to be $631,247,629,129, with the lowest PRGO revenue forecast at $621,292,219,416, and the highest PRGO revenue forecast at $640,888,572,755.
In 2026, PRGO is forecast to generate $651,917,805,714 in revenue, with the lowest revenue forecast at $634,389,288,600 and the highest revenue forecast at $668,677,688,579.